Home
Sitemap
|
Contact
Home
Therapeutic Areas
Portfolio
Technology Platform
Media
About ACE BioSciences
2008
Filter
Display #
5
10
15
20
25
30
50
100
All
#
Article Title
1
Nov 07th 09 - Zymenex acquires ACE Biosciences
2
Dec 1st 08 - ACE BioSciences Begins Landmark Phase IIb Proof of Concept Study with its Travellers’ Diarrhoea Vaccine, ACE393
3
August 19th 08 - ACE BioSciences Appoints Shire’s Business Development Expert, David Colpman to its Board
4
ACE BioSciences and PATH announce new collaboration to develop a vaccine against diarrheal disease
5
May 19th 08 - ACE BioSciences Rearms with Peter Birk as new CSO
6
March 11th 08 - ACE BioSciences Enters Research Collaboration with PATH to Develop Temperature Stable, Oral ETEC
7
March 3rd 08 - ACE BioSciences appoints Biotecnol SA to develop a robust, commercial scale manufacturing process for its Travellers' Diarrhoea vaccine ACE393
© ACE BioSciences A/S - Updated June 2009
